Previous studies have shown that estrogen receptor (ER) and progesterone receptor (PR) positives are higher in geriatric breast cancer (GBC), with less overexpression of epidermal growth factor receptor (EGFR), human epidermal growth factor receptor 2 (HER2), and ki67 [6]. This evidence concerns the gene ESR1 and breast cancer.